← Fulgent Genetics, Inc.
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||
| Current assets: | |||||||||||
| Cash and Cash Equivalents, at Carrying Value | $7.9m | $6.5m | $6.7m | $12.0m | $87.4m | $164.9m | $79.5m | $97.5m | $55.1m | $50.2m | |
| Assets, Current | $26.1m | $32.9m | $39.5m | $37.1m | $523.6m | $612.0m | $627.9m | $507.8m | $353.6m | $550.5m | |
| Property, Plant and Equipment, Net | $6.2m | $7.3m | $6.4m | $6.0m | $40.2m | $62.3m | $81.4m | $83.5m | $105.5m | $112.5m | |
| Goodwill | — | — | — | — | — | $50.9m | $143.0m | $22.1m | $22.1m | $25.1m | |
| Intangible Assets, Net (Excluding Goodwill) | — | — | — | — | — | $35.9m | $150.6m | $143.1m | $135.0m | $133.3m | |
| Operating Lease, Right-of-Use Asset | — | — | — | $2.6m | $828k | $7.1m | $14.8m | $10.8m | $5.4m | $5.0m | |
| Other Assets, Noncurrent | $17k | $39k | $17k | $251k | $3.3m | $10.7m | $44.1m | $34.9m | $33.5m | $22.9m | |
| Additional Financial Items | |||||||||||
| Accounts Receivable, after Allowance for Credit Loss, Current | $4.4m | $4.0m | $5.9m | $6.6m | $183.9m | $138.9m | $52.7m | $51.1m | $69.0m | $84.8m | |
| Accrued Liabilities, Current | $436k | $911k | $1.4m | $1.3m | $8.4m | $17.7m | $25.0m | $30.7m | $24.3m | $34.1m | |
| Assets | $58.0m | $57.2m | $53.9m | $88.8m | $700.5m | $1.3b | $1.4b | $1.2b | $1.2b | $1.2b | |
| LIABILITIES AND EQUITY | |||||||||||
| Current liabilities: | |||||||||||
| Operating Lease, Liability, Current | — | — | — | $420k | $267k | $1.8m | $6.1m | $4.0m | $1.4m | $1.5m | |
| Accounts Payable, Current | $2.8m | $2.1m | $1.3m | $1.6m | $26.5m | $20.5m | $23.1m | $15.4m | $18.4m | $18.7m | |
| Operating Lease, Liability, Noncurrent | — | — | — | $2.3m | $568k | $5.3m | $8.8m | $7.1m | $4.1m | $3.8m | |
| Liabilities, Current | $3.3m | $3.0m | $2.7m | $3.7m | $130.1m | $105.3m | $88.1m | $73.0m | $72.9m | $85.0m | |
| Deferred Income Tax Liabilities, Net | — | — | — | — | — | — | — | $8.0m | $6.4m | $6.9m | |
| Other Liabilities, Noncurrent | $2k | $6k | $14k | — | $14k | $6.8m | $18.2m | $15.1m | $7.0m | $7.6m | |
| Deferred Tax Liabilities, Net | $189k | — | — | — | — | — | — | — | — | — | |
| Liabilities | $3.6m | $3.0m | $2.8m | $6.0m | $131.1m | $112.8m | $116.2m | $102.0m | $90.8m | $106.8m | |
| Stockholders’ equity: | |||||||||||
| Common Stock, Value, Issued | $2k | $2k | $2k | $2k | $3k | $3k | $3k | $3k | $3k | $3k | |
| Additional Paid in Capital | $109.7m | $111.9m | $114.2m | $146.1m | $418.1m | $501.9m | $486.6m | $501.7m | $543.1m | $574.5m | |
| Retained Earnings (Accumulated Deficit) | ($55.2m) | ($57.7m) | ($63.0m) | ($63.4m) | $150.9m | $657.6m | $801.0m | $633.2m | $590.5m | $530.0m | |
| Accumulated Other Comprehensive Income (Loss), Net of Tax | ($103k) | ($44k) | ($35k) | $146k | $438k | ($759k) | ($20.9m) | $1.2m | ($368k) | $7.5m | |
| Additional Paid in Capital, Common Stock | — | $111.9m | $114.2m | $146.1m | $418.1m | $501.9m | $486.6m | $501.7m | $543.1m | $574.5m | |
| Stockholders' Equity Attributable to Parent | $54.5m | $54.2m | $51.2m | $82.8m | $569.4m | $1.2b | $1.3b | $1.1b | $1.1b | $1.1b | |
| Stockholders' Equity Attributable to Noncontrolling Interest | — | — | — | — | — | $7.1m | $3.2m | ($2.8m) | ($4.1m) | ($5.3m) | |
| Liabilities and Equity | $58.0m | $57.2m | $53.9m | $88.8m | $700.5m | $1.3b | $1.4b | $1.2b | $1.2b | $1.2b |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.